The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of cabozantinib and temozolomide in patients with unresectable or metastatic leiomyosarcoma and other soft tissue sarcomas.
 
Mark Agulnik
Consulting or Advisory Role - AADi; Coherus Biosciences; Regeneron
Speakers' Bureau - Bayer; Deciphera
Research Funding - Exelixis (Inst)
 
Scott H. Okuno
Consulting or Advisory Role - Boehringer Ingelheim
 
Brian Andrew Van Tine
Leadership - Polaris
Honoraria - Bionest Partner; Horizon CME; Research to Practice; Targeted Oncology
Consulting or Advisory Role - Adaptimmune; ADRx; Apexigen; Ayala Pharmaceuticals; Bayer; Boehringer Ingelheim; Cytokinetics; Daiihi Sankyo; Deciphera; EcoR1 Capital; EcoR1 Capital; EMD Serono; Epizyme; GlaxoSmithKline; Immune Design; Intellisphere; Lilly; Novartis; Pfizer; PTC Therapeutics
Speakers' Bureau - Adaptimmune; GlaxoSmithKline; Lilly; Novartis
Research Funding - GlaxoSmithKline; Merck; Pfizer; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Accuronix Therapeutics- Licensing agreement. Sigma-2 Receptor Ligands and Therapeutic uses therefor (006766), • Modular Platform for Targeted Therapeutic Delivery (006755), • Sigma-2 Receptor Ligand Drug Conjugates as Antitumor Compounds, Methods of synth; Patent on ALEXT3102; Patent on the use of ME1 as a biomarker
Expert Testimony - Health Advances
Travel, Accommodations, Expenses - Adaptimmune; Advenchen Laboratories; GlaxoSmithKline; Lilly
 
Seth Pollack
Consulting or Advisory Role - AADi; Apexigen; Bayer; Daichii Sankyo; Deciphera; Epizyme; GlaxoSmithKline; Obsidian Therapeutics; Sensei Biotherapeutics; T-Knife
Speakers' Bureau - Deciphera
Research Funding - Obsidian Therapeutics (Inst)
 
Mia C. Weiss
No Relationships to Disclose
 
Angela C. Hirbe
Honoraria - Empartners
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca; Intellisphere, LLC; SpringWorks Therapeutics
Research Funding - Tango Therapeutics
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim RCV GmBH & Co KG- Licensing- T-019044 Development of a Preclinical NF1-MPNST Platform Suitable for Precision Oncology Drug Discovery and Evaluation. Royalities paid through the University; Deutsches Krebsforschungszentrum-licensing agreement for PDX cell lines. Paid through the University. (Inst)
Travel, Accommodations, Expenses - Alexion Pharmaceuticals; SpringWorks Therapeutics
 
Pedro Viveiros
No Relationships to Disclose
 
Brian Schulte
Employment - Abbott Laboratories (I)
Consulting or Advisory Role - AADi; Caris Life Sciences
 
Paul Henry Frankel
Stock and Other Ownership Interests - Asensus Surgical; Geron
Consulting or Advisory Role - Johnson & Johnson/Janssen
 
Steven Attia
Research Funding - AB Science (Inst); Adaptimmune (Inst); Advenchen Laboratories (Inst); Ayala Pharmaceuticals (Inst); Bavarian Nordic (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); BTG (Inst); C4 Therapeutics (Inst); CBA Pharma (Inst); Deciphera (Inst); Desmoid Tumor Research Foundation; Epizyme (Inst); FORMA Therapeutics (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Gradalis (Inst); Incyte (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Monopar Therapeutics (Inst); Novartis (Inst); Noxopharm (Inst); Philogen (Inst); PTC Therapeutics (Inst); Rain Therapeutics (Inst); Salarius Pharmaceuticals (Inst); SpringWorks Therapeutics (Inst); Takeda (Inst); Theseus Pharmaceuticals (Inst); TRACON Pharma (Inst); TRACON Pharma (Inst); Trillium Therapeutics (Inst)
 
Brittany L. Siontis
No Relationships to Disclose
 
Mohammed M. Milhem
Consulting or Advisory Role - Exicure
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)
 
Varun Monga
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); C4 Therapeutics (Inst); Cogent Biosciences (Inst); Hutchison MediPharma (Inst); Oblato (Inst); Pfizer (Inst); Prelude Therapeutics (Inst)
Travel, Accommodations, Expenses - Cogent Biosciences
 
John A. Charlson
Consulting or Advisory Role - Adaptimmune; Deciphera
Research Funding - Lilly (Inst)
 
Steven Ian Robinson
Honoraria - AADi (Inst); BTG (Inst); HMP; Intellisphere (Inst); Medpace (Inst); TRACON Pharma (Inst)
Consulting or Advisory Role - AADi (Inst); BTG (Inst); Medpace (Inst); TRACON Pharma (Inst)
Research Funding - TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Cogent Biosciences (Inst); GlaxoSmithKline (Inst); Society of Interventional Radiology Foundation (Inst); TRACON Pharma (Inst)
 
Janet Yoon
Consulting or Advisory Role - Sanofi